The impact of medical and recreational marijuana laws on opioid prescribing in employer‐sponsored health insurance
Using data from Truven Health MarketScan Commercial Claims and Encounters Database between 2009 and 2015, we studied the effects of medical and recreational marijuana laws on opioid prescribing in employer‐sponsored health insurance. We used a differences‐in‐differences (DD) approach and found that...
Gespeichert in:
| Veröffentlicht in: | Health economics 2021-05, Vol.30 (5), p.989-1000 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1000 |
|---|---|
| container_issue | 5 |
| container_start_page | 989 |
| container_title | Health economics |
| container_volume | 30 |
| creator | Wen, Jiebing Wen, Hefei Butler, J. S. Talbert, Jeffery C. |
| description | Using data from Truven Health MarketScan Commercial Claims and Encounters Database between 2009 and 2015, we studied the effects of medical and recreational marijuana laws on opioid prescribing in employer‐sponsored health insurance. We used a differences‐in‐differences (DD) approach and found that the implementation of medical marijuana laws (MMLs) and recreational marijuana laws (RMLs) reduced morphine milligram equivalents per enrollee by 7% and 13%, respectively. The reduction associated with MMLs was predominately in people aged 55–64, whereas the reduction associated with RMLs was largely in people aged 35–44 and aged 45–54. Our findings suggest that both MMLs and RMLs have the potential to reduce opioid prescribing in the privately insured population, especially for the middle‐aged population. |
| doi_str_mv | 10.1002/hec.4237 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8237244</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2493005891</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4717-ac0ee6e502d143690ed16d9c23cc91da857b57796c4c8fd9f5d9efe389e24d523</originalsourceid><addsrcrecordid>eNp1kd1qFTEQx4MotlbBJ5CAN95snST7lRtBDq0VCt7U65CTzHZzyCZrsms5dz6Cz-iTNMfW-gFeZcj8-DEzf0JeMjhlAPztiOa05qJ7RI4ZSFkxaODxoW66SnIBR-RZzjuA0oP2KTkSouW16LtjslyNSN00a7PQONAJrTPaUx0sTWgS6sXFUD4mndxu1UFTr28yjYHG2UVn6Zwwm-S2LlxTFyhOs497TD--fc9zDDkmtHRE7ZextPOadDD4nDwZtM_44v49IZ_Pz642F9Xlpw8fN-8vK1N3rKu0AcQWG-CW1aKVgJa1VhoujJHM6r7ptk3XydbUph-sHBorcUDRS-S1bbg4Ie_uvPO6LZsZDEvSXs3JlXX2Kmqn_u4EN6rr-FX15Za8rovgzb0gxS8r5kVNLhv0XgeMa1a8lgKg6SUr6Ot_0F1cUzldoRrWggQB8rfQpJhzwuFhGAbqEKUqUapDlAV99efwD-Cv7ApQ3QE3zuP-vyJ1cbb5KbwFZjirWQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2516090309</pqid></control><display><type>article</type><title>The impact of medical and recreational marijuana laws on opioid prescribing in employer‐sponsored health insurance</title><source>MEDLINE</source><source>Wiley Journals</source><source>Applied Social Sciences Index & Abstracts (ASSIA)</source><creator>Wen, Jiebing ; Wen, Hefei ; Butler, J. S. ; Talbert, Jeffery C.</creator><creatorcontrib>Wen, Jiebing ; Wen, Hefei ; Butler, J. S. ; Talbert, Jeffery C.</creatorcontrib><description>Using data from Truven Health MarketScan Commercial Claims and Encounters Database between 2009 and 2015, we studied the effects of medical and recreational marijuana laws on opioid prescribing in employer‐sponsored health insurance. We used a differences‐in‐differences (DD) approach and found that the implementation of medical marijuana laws (MMLs) and recreational marijuana laws (RMLs) reduced morphine milligram equivalents per enrollee by 7% and 13%, respectively. The reduction associated with MMLs was predominately in people aged 55–64, whereas the reduction associated with RMLs was largely in people aged 35–44 and aged 45–54. Our findings suggest that both MMLs and RMLs have the potential to reduce opioid prescribing in the privately insured population, especially for the middle‐aged population.</description><identifier>ISSN: 1057-9230</identifier><identifier>ISSN: 1099-1050</identifier><identifier>EISSN: 1099-1050</identifier><identifier>DOI: 10.1002/hec.4237</identifier><identifier>PMID: 33624387</identifier><language>eng</language><publisher>England: Wiley Periodicals Inc</publisher><subject>Adult ; Analgesics, Opioid - administration & dosage ; Cannabis ; Drug legalization ; Health economics ; Health insurance ; Humans ; Insurance, Health ; Marijuana ; Marijuana Use - legislation & jurisprudence ; Medical Marijuana ; medical marijuana laws ; Middle Aged ; Morphine ; Narcotics ; Opioids ; pain management ; Practice Patterns, Physicians ; Prescribing ; prescription opioids ; Recreation ; recreational marijuana laws ; United States</subject><ispartof>Health economics, 2021-05, Vol.30 (5), p.989-1000</ispartof><rights>2021 John Wiley & Sons Ltd.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4717-ac0ee6e502d143690ed16d9c23cc91da857b57796c4c8fd9f5d9efe389e24d523</citedby><cites>FETCH-LOGICAL-c4717-ac0ee6e502d143690ed16d9c23cc91da857b57796c4c8fd9f5d9efe389e24d523</cites><orcidid>0000-0001-5064-2501</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fhec.4237$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fhec.4237$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>230,314,780,784,885,1417,27924,27925,30999,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33624387$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wen, Jiebing</creatorcontrib><creatorcontrib>Wen, Hefei</creatorcontrib><creatorcontrib>Butler, J. S.</creatorcontrib><creatorcontrib>Talbert, Jeffery C.</creatorcontrib><title>The impact of medical and recreational marijuana laws on opioid prescribing in employer‐sponsored health insurance</title><title>Health economics</title><addtitle>Health Econ</addtitle><description>Using data from Truven Health MarketScan Commercial Claims and Encounters Database between 2009 and 2015, we studied the effects of medical and recreational marijuana laws on opioid prescribing in employer‐sponsored health insurance. We used a differences‐in‐differences (DD) approach and found that the implementation of medical marijuana laws (MMLs) and recreational marijuana laws (RMLs) reduced morphine milligram equivalents per enrollee by 7% and 13%, respectively. The reduction associated with MMLs was predominately in people aged 55–64, whereas the reduction associated with RMLs was largely in people aged 35–44 and aged 45–54. Our findings suggest that both MMLs and RMLs have the potential to reduce opioid prescribing in the privately insured population, especially for the middle‐aged population.</description><subject>Adult</subject><subject>Analgesics, Opioid - administration & dosage</subject><subject>Cannabis</subject><subject>Drug legalization</subject><subject>Health economics</subject><subject>Health insurance</subject><subject>Humans</subject><subject>Insurance, Health</subject><subject>Marijuana</subject><subject>Marijuana Use - legislation & jurisprudence</subject><subject>Medical Marijuana</subject><subject>medical marijuana laws</subject><subject>Middle Aged</subject><subject>Morphine</subject><subject>Narcotics</subject><subject>Opioids</subject><subject>pain management</subject><subject>Practice Patterns, Physicians</subject><subject>Prescribing</subject><subject>prescription opioids</subject><subject>Recreation</subject><subject>recreational marijuana laws</subject><subject>United States</subject><issn>1057-9230</issn><issn>1099-1050</issn><issn>1099-1050</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>7QJ</sourceid><recordid>eNp1kd1qFTEQx4MotlbBJ5CAN95snST7lRtBDq0VCt7U65CTzHZzyCZrsms5dz6Cz-iTNMfW-gFeZcj8-DEzf0JeMjhlAPztiOa05qJ7RI4ZSFkxaODxoW66SnIBR-RZzjuA0oP2KTkSouW16LtjslyNSN00a7PQONAJrTPaUx0sTWgS6sXFUD4mndxu1UFTr28yjYHG2UVn6Zwwm-S2LlxTFyhOs497TD--fc9zDDkmtHRE7ZextPOadDD4nDwZtM_44v49IZ_Pz642F9Xlpw8fN-8vK1N3rKu0AcQWG-CW1aKVgJa1VhoujJHM6r7ptk3XydbUph-sHBorcUDRS-S1bbg4Ie_uvPO6LZsZDEvSXs3JlXX2Kmqn_u4EN6rr-FX15Za8rovgzb0gxS8r5kVNLhv0XgeMa1a8lgKg6SUr6Ot_0F1cUzldoRrWggQB8rfQpJhzwuFhGAbqEKUqUapDlAV99efwD-Cv7ApQ3QE3zuP-vyJ1cbb5KbwFZjirWQ</recordid><startdate>202105</startdate><enddate>202105</enddate><creator>Wen, Jiebing</creator><creator>Wen, Hefei</creator><creator>Butler, J. S.</creator><creator>Talbert, Jeffery C.</creator><general>Wiley Periodicals Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QJ</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-5064-2501</orcidid></search><sort><creationdate>202105</creationdate><title>The impact of medical and recreational marijuana laws on opioid prescribing in employer‐sponsored health insurance</title><author>Wen, Jiebing ; Wen, Hefei ; Butler, J. S. ; Talbert, Jeffery C.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4717-ac0ee6e502d143690ed16d9c23cc91da857b57796c4c8fd9f5d9efe389e24d523</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Adult</topic><topic>Analgesics, Opioid - administration & dosage</topic><topic>Cannabis</topic><topic>Drug legalization</topic><topic>Health economics</topic><topic>Health insurance</topic><topic>Humans</topic><topic>Insurance, Health</topic><topic>Marijuana</topic><topic>Marijuana Use - legislation & jurisprudence</topic><topic>Medical Marijuana</topic><topic>medical marijuana laws</topic><topic>Middle Aged</topic><topic>Morphine</topic><topic>Narcotics</topic><topic>Opioids</topic><topic>pain management</topic><topic>Practice Patterns, Physicians</topic><topic>Prescribing</topic><topic>prescription opioids</topic><topic>Recreation</topic><topic>recreational marijuana laws</topic><topic>United States</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wen, Jiebing</creatorcontrib><creatorcontrib>Wen, Hefei</creatorcontrib><creatorcontrib>Butler, J. S.</creatorcontrib><creatorcontrib>Talbert, Jeffery C.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Applied Social Sciences Index & Abstracts (ASSIA)</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Health economics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wen, Jiebing</au><au>Wen, Hefei</au><au>Butler, J. S.</au><au>Talbert, Jeffery C.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The impact of medical and recreational marijuana laws on opioid prescribing in employer‐sponsored health insurance</atitle><jtitle>Health economics</jtitle><addtitle>Health Econ</addtitle><date>2021-05</date><risdate>2021</risdate><volume>30</volume><issue>5</issue><spage>989</spage><epage>1000</epage><pages>989-1000</pages><issn>1057-9230</issn><issn>1099-1050</issn><eissn>1099-1050</eissn><abstract>Using data from Truven Health MarketScan Commercial Claims and Encounters Database between 2009 and 2015, we studied the effects of medical and recreational marijuana laws on opioid prescribing in employer‐sponsored health insurance. We used a differences‐in‐differences (DD) approach and found that the implementation of medical marijuana laws (MMLs) and recreational marijuana laws (RMLs) reduced morphine milligram equivalents per enrollee by 7% and 13%, respectively. The reduction associated with MMLs was predominately in people aged 55–64, whereas the reduction associated with RMLs was largely in people aged 35–44 and aged 45–54. Our findings suggest that both MMLs and RMLs have the potential to reduce opioid prescribing in the privately insured population, especially for the middle‐aged population.</abstract><cop>England</cop><pub>Wiley Periodicals Inc</pub><pmid>33624387</pmid><doi>10.1002/hec.4237</doi><tpages>12</tpages><orcidid>https://orcid.org/0000-0001-5064-2501</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1057-9230 |
| ispartof | Health economics, 2021-05, Vol.30 (5), p.989-1000 |
| issn | 1057-9230 1099-1050 1099-1050 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8237244 |
| source | MEDLINE; Wiley Journals; Applied Social Sciences Index & Abstracts (ASSIA) |
| subjects | Adult Analgesics, Opioid - administration & dosage Cannabis Drug legalization Health economics Health insurance Humans Insurance, Health Marijuana Marijuana Use - legislation & jurisprudence Medical Marijuana medical marijuana laws Middle Aged Morphine Narcotics Opioids pain management Practice Patterns, Physicians Prescribing prescription opioids Recreation recreational marijuana laws United States |
| title | The impact of medical and recreational marijuana laws on opioid prescribing in employer‐sponsored health insurance |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T04%3A10%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20impact%20of%20medical%20and%20recreational%20marijuana%20laws%20on%20opioid%20prescribing%20in%20employer%E2%80%90sponsored%20health%20insurance&rft.jtitle=Health%20economics&rft.au=Wen,%20Jiebing&rft.date=2021-05&rft.volume=30&rft.issue=5&rft.spage=989&rft.epage=1000&rft.pages=989-1000&rft.issn=1057-9230&rft.eissn=1099-1050&rft_id=info:doi/10.1002/hec.4237&rft_dat=%3Cproquest_pubme%3E2493005891%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2516090309&rft_id=info:pmid/33624387&rfr_iscdi=true |